Committed to the discovery, development and commercialization of oral direct-acting antiviral therapies.🔒 SSL Verified
Live Data Status: |News & Media
Welcome to the detailed analysis for ateapharma.com. This domain is officially recognized as Home - Atea Pharmaceuticals. According to their official web presence, their primary focus is: "Atea Pharmaceuticals is a leader in the discovery of oral direct-acting antiviral therapies, including our most advanced drug candidate, bemnifosbuvir (AT-527).".
Table of Contents
- ↓ Regimen of bemnifosbuvir / ruzasvir
- ↓ Combining innovative discoveries with development expertise to advance antivirals with the potential to transform treatments for patients with serious viral diseases.
- ↓ Our science.
- ↓ Follow our progress.
- ↓ Atea Pharmaceuticals announces strategic collaboration with Roche to develop and commercialize AT-527 for patients with COVID-19.
- ↓ Top Alternatives to ateapharma.com
- Tech Stack
- WordPress
- Link Profile
- Internal Pages: 44Outbound Links: 0
- Localization
- en
6-Month Traffic Trend Estimate
M1
M2
M3
M4
M5
M6
Estimated Market Value
$16,872
Based on domain age, authority, and keyword relevance.
TLD Availability Risk
- ateapharma.comTaken
- ateapharma.netTaken
- ateapharma.orgTaken
- ateapharma.ioTaken
- ateapharma.coAvailable
- ateapharma.aiAvailable
Content Snippets from ateapharma.com
"The regimen of bemnifosbuvir, a nucleotide analog polymerase inhibitor and ruzasvir, an NS5A inhibitor, is advancing in a global Phase 3 development program for the treatment of hepatitis C virus (HCV). In a global Phase 2 study, the regimen met its primary endpoints of efficacy and safety. As single agents, both bemnifosbuvir and ruzasvir have demonstrated potent pan-genotypic antiviral activity against HCV."
"Atea is a clinical stage biopharmaceutical company working to address unmet medical needs with innovative oral antiviral therapies."
"Leveraging our deep understanding of antiviral drug development, medicinal chemistry, biology, biochemistry and virology, we are discovering and developing novel product candidates to treat single stranded ribonucleic acid, or ssRNA, viruses, which are a prevalent cause of serious viral diseases. Currently, we are focused on the development of orally-available direct-acting antiviral agents for the treatment of hepatitis C virus (HCV)."
"Updates on the regimen of bemnifosbuvir and ruzasvir for the treatment of HCV and"
Key Topics & Focus Areas for ateapharma.com:
Regimen of bemnifosbuvir / ruzasvir
Combining innovative discoveries with development expertise to advance antivirals with the potential to transform treatments for patients with serious viral diseases.
Our science.
Follow our progress.
Atea Pharmaceuticals announces strategic collaboration with Roche to develop and commercialize AT-527 for patients with COVID-19.
By comparing ateapharma.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to ateapharma.com.
Frequently Asked Questions
Is ateapharma.com a safe and secure website?
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
What is the authority score of ateapharma.com?
As of July 25, 2026, ateapharma.com holds an estimated domain authority score of 74/100 based on our VisitRank tracking algorithms.
What are the top alternatives to ateapharma.com?
You can find the best alternatives and similar sites to ateapharma.com in our explore section, which includes competitors in the News & Media sector.
Data Sources & Methodology: DNS telemetry and routing records are resolved via live root servers. Market valuation estimates are computed algorithmically based on proprietary historical indexation multiples and standardized digital asset appraisal methodologies.
Common Misspellings & Typo Domains for ateapharma.com:
aetapharma.comatapharma.comatteapharma.cometeapharma.comataapharma.comateepharma.comateapherma.comateapharme.comareapharma.comafeapharma.com